Inclacumab | Interleukin Related interleukin-related.com

Product Name :
Inclacumab

Search keywords :
Inclacumab

drugId :
null

Target Vo:
P-selectin

Target Vo Short Name :
SELP

Moa_Name:
Immunostimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Genmab A/S

Active Company_Name :
Pfizer Inc

Active Indication_Name:
Anemia, Sickle Cell

In Active Indication_Name:
Peripheral Arterial Disease

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SOD2 Antibody (YA071)
Argonaute 2 Antibody
NOX2 Antibody: NOX2 Antibody is an unconjugated, approximately 65 kDa, rabbit-derived, anti-NOX2 polyclonal antibody. NOX2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, rabbit background without labeling.

Author: Interleukin Related

Related Posts